The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension
Isil KeskiniD, Elin Forsgren, Manuela Lehmann, Peter Munch AnderseniD, Thomas BrännströmiD, Dale J. LangeiD, Matthis SynofzikiD, Ulrika NordströmiD, Per ZetterströmiD, Stefan L. MarklundiD, Jonathan D. GilthorpeiD
Abstract
Mutations that destabilize superoxide dismutase 1 (SOD1) are a cause of amyotrophic lateral sclerosis (ALS). SOD1, which is located in the reducing cytosol, contains an oxidized disulfide bond required for stability. We show that the bond is an Achilles heel of the protein because it is sensitive to the oxygen tension. Culture of ALS patient-derived fibroblasts, astrocytes and induced pluripotent stem cell-derived mixed motor neuron and astrocyte cultures (MNACs) under lowered oxygen tensions caused reductive bond cleavage and misfolding. The effects were greatest in cells expressing mutant SOD1s, but also occurred in wild type SOD1 in cultures derived from patients carrying ALS-linked mutations in C9orf72, FUS and TBK1, as well as from controls. MNACs showed a greater response than the other cell types, including enhanced SOD1 aggregation, in line with the vulnerability of the motor system. Our results show that oxygen tension is a principal determinant of SOD1 stability and shed light on how risk factors for ALS, such as aging and other conditions causing reduced vascular perfusion, could lead to disease initiation and progression.\n\nSubject categories Neuroscience; Molecular Biology of Disease
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 27
- FWCI
- 2.88
- Field percentile
- top 9%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Oxidative stress profiles of lymphoblasts from Amyotrophic Lateral Sclerosis patients with or without known SOD1 Mutations
T. Cunha-Oliveira, D. F. Silva, … F. S. G. Silva·bioRxiv·Mar 3, 2022
- Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death.
Pablo Martínez, Mónica Silva, … Brigitte van Zundert·Molecular MedicinePeer-reviewed·Oct 25, 2024
- The structure, redox chemistry and motor neuron toxicity of heterodimeric zinc-deficient SOD1-Implications for the toxic gain of function observed in ALS.
Victor A. Streltsov, Katherine Ganio, … Blaine Russell Roberts·Neurobiology of DiseasePeer-reviewed·Nov 16, 2025
- Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS mice
Alexandra I. Mot, Ying Li, … Klaus‐Armin Nave·bioRxiv·Jun 11, 2026
- Uncovering moonlighting role of mitochondrial presequence translocase machinery in SOD1-mediated ALS pathogenesis
Tejashree Pradip Waingankar, Aakansha Paliwal, … Patrick D’Silva·bioRxiv·Jun 6, 2026
- Superoxide Dismutase 1 translocates to the nucleus in spinal cord mixed cells from newborn rats
G. Cerchiaro, N. Santos, C. M. L. Machado·bioRxiv·Mar 8, 2022